Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
4 Patents
#124 in Grand Cayman
#168 in Cayman Islands
I-Mab
Forward Citations = 23
6 inventors:
I-Mab
CIPO Patents = 4
Forward Citations = 23
Loading Chart...
Loading Chart...
6 inventors (with patents filed for the assignee):
Lei Fang (4 out of 39 patents)
Bingshi Guo (4 out of 18 patents)
Zhengyi Wang (4 out of 18 patents)
4. Jingwu Zang (4 out of 17 patents)
5. Wenqing Jiang (1 out of 8 patents)
6. Yongqiang Wang (1 out of 19 patents)
4 patents:
Company Overview
I-mab is a clinical-stage biopharmaceutical company committed to the research, development, and commercialization of novel and highly differentiated biologics in immunology and oncology. Their pipeline includes multiple drug candidates in various stages of development targeting cancer and autoimmune diseases.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: I-Mab. Retrieved from https://idiyas.com/company/i-mab
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
4 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]